市場調査レポート
商品コード
1477065

白斑治療の世界市場:2033年までの機会と戦略

Vitiligo Treatment Global Market Opportunities And Strategies To 2033

出版日: | 発行: The Business Research Company | ページ情報: 英文 271 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
白斑治療の世界市場:2033年までの機会と戦略
出版日: 2024年05月09日
発行: The Business Research Company
ページ情報: 英文 271 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の白斑治療市場は2018年に12億3,720万米ドルと評価され、CAGR2.0%以上で2023年まで成長しました。

白斑の認知度向上

白斑の認知度の向上は、歴史的な期間における白斑治療市場の成長に貢献しました。尋常性白斑の認知度の向上は、医療従事者や一般市民によるその適応症や症状の認知度向上につながった。その結果、より多くの白斑患者が早期に発見され、診断されるようになった。早期発見によりタイムリーな治療が可能となり、白斑の進行管理や治療の成功率の向上に役立っています。例えば、2020年5月、エジプトを拠点とする査読付きオープンアクセス科学雑誌出版社Hindawiが368人の被験者を対象に実施した調査によると、30歳以上50歳未満の人は白斑関連の知識スコアが高く、43.3%の人が白斑に対して肯定的な態度を示しました。従って、白斑に対する認識の高まりが、歴史的な期間における白斑治療の需要を牽引しました。

目次

1エグゼクティブサマリー

  • 白斑治療-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポートの構造

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 白斑治療市場定義とセグメンテーション
  • 市場セグメンテーション:薬剤タイプ別
    • コルチコステロイド
    • カルシニューリン阻害剤
    • その他の薬剤の選択肢
  • 市場セグメンテーション:疾患タイプ別
    • 非分節性白斑
    • 分節性白斑
  • 市場セグメンテーション:治療別
    • 薬剤
    • 治療法
    • その他の治療オプション
  • 市場セグメンテーション:エンドユーザー別
    • 病院
    • 在宅ケア
    • 専門クリニック
    • その他のエンドユーザー

第7章 主要な市場動向

  • 白斑予防治療のための独自開発キットのイントロダクション
  • 白斑治療のための新しい治療法やクリームの承認
  • 白斑治療調査を推進するための戦略的コラボレーションとパートナーシップ
  • 次世代白斑治療の臨床試験の調査

第8章 白斑治療市場:マクロ経済シナリオ

  • COVID-19の影響白斑治療市場
  • ウクライナ戦争の影響、白斑治療市場
  • 高インフレの影響白斑治療市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測、2023-2028、2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第10章 世界の白斑治療市場:セグメンテーション

  • 世界の白斑治療市場:薬剤タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の白斑治療市場:疾患タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の白斑治療市場:エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の白斑治療市場:治療別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の医薬品市場:流通チャネル別、実績と予測, 2018-2023, 2028F, 2033F

第11章 白斑治療市場:地域・国別分析

  • 世界の白斑治療市場:地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の白斑治療市場:国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Incyte Corporation
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Dr. Reddy's Laboratories Ltd
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Glenmark Pharmaceuticals Ltd
    • 会社概要
    • 製品・サービス
    • 財務概要
  • Strides Pharma Science Limited
    • 会社概要
    • 製品・サービス
    • 財務概要
  • Issar Pharmaceuticals Pvt Ltd
    • 会社概要
    • 製品・サービス
    • 財務概要

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Incyte Acquired Villaris Therapeutics
  • Bristol Myers Squibb Acquired Celgene Corporation
  • Crown Laboratories Acquired Crown Aesthetics

第23章 機会と戦略

  • 2028年の世界市場:新たな機会を提供する国
  • 2028年の世界市場:新たな機会を提供するセグメント
  • 2028年の世界市場:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第24章 白斑治療市場:結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第25章 付録

目次
Product Code: o&s1099

Vitiligo treatment encompasses a range of medical strategies aimed at managing vitiligo, a condition characterized by the loss of skin color in patches. This condition results from the destruction or malfunction of melanocytes, cells responsible for producing melanin, the pigment that gives skin its color.

The vitiligo treatment market consists of revenues earned by entities (organizations, sole traders and partnerships) that manufacture, distribute and sell medications and provide services designed to treat vitiligo.

The global vitiligo treatment market was valued at $1,237.2 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 2.0%.

Increased Awareness Of Vitiligo

The increased awareness of vitiligo contributed to the growth of the vitiligo treatment market during the historic period. Increased awareness of vitiligo has resulted in increased recognition of its indications and symptoms by healthcare professionals and the general public. As a result, more vitiligo patients have been found and diagnosed at an earlier stage of the disease. Early detection enables timely treatment, which helps to manage vitiligo progression and enhanced treatment success. For instance, in May 2020, according to a survey conducted among 368 subjects by Hindawi, an Egypt-based peer-reviewed, open-access scientific journal publishing company, people over the age of 30 and under the age of 50 had higher vitiligo-related knowledge scores, and 43.3% of individuals expressed positive attitudes toward vitiligo. Therefore, increased awareness of vitiligo drove the demand for vitiligo treatment during the historic period.

The vitiligo treatment market benefited from strong economic growth in developing countries during the historic period. The economic growth of developing countries led to growth in healthcare infrastructure and a rise in healthcare spending, supporting the demand for vitiligo treatment. For instance, China's GDP grew from $12.84 trillion in 2017, to $17.94 trillion in 2022.

Introduction Of Self-Designed Kits For Preventive Vitiligo Treatment

Companies in the vitiligo treatment market are introducing self-designed kits for preventive vitiligo therapy as a proactive method for treating the condition and reducing its impact on people's lives. These kits contain a comprehensive range of tools, treatments and materials, designed to prevent the beginning or progression of vitiligo and promote skin health. For instance, in September 2021, Vedas Cure, an India-based online Ayurveda treatment center, introduced a customized range of self-designed kits, comprising of Vitiligo Derma Care, Psoralea oil and a tablet for patients suffering from early Vitiligo symptoms, such as white spots on the skin. The Vedas Cure package includes vitiligo medications such as Kaishor Guggulu, Derma Care Powder and Psoralea oil, commonly known as Babchi oil. Psoralea oil, applied locally, is useful for curing vitiligo. It spreads skin color equally on white patches, minimizing the concentration of white elements in a particular location.

The global vitiligo treatment market is fairly fragmented, with a large number of players operating in the market. The top five competitors in the market made up to 17.1% of the total market in 2022.

Vitiligo Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global vitiligo treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for vitiligo treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The vitiligo treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider vitiligo treatment market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions, and explanations about the segment by drugs type, by disease type, by treatment, by distribution channel and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the vitiligo treatment market.
  • Global Market Size and Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by drugs type, by disease type, by treatment, by distribution channel and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth-Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard-Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for vitiligo treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Drugs Type: Corticosteroids; Calcineurin Inhibitors; Other Drug Options
  • 2) By Disease Type: Nonsegmental Vitiligo; Segmental Vitiligo
  • 3) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • 4) By Treatment: Medication; Therapies; Other Treatment Options
  • 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Incyte Corporation; Dr. Reddy's Laboratories Ltd; Glenmark Pharmaceuticals Ltd; Strides Pharma Science Limited; Issar Pharmaceuticals Pvt
  • Countries: Australia; China; India; Indonesia; Japan; South Korea; Brazil; Russia; USA; Canada; France, Germany; UK; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; vitiligo treatment indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1Executive Summary

  • 1.1 Vitiligo Treatment - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Vitiligo Treatment Market Definition And Segmentations
  • 6.4 Market Segmentation By Drugs Type
    • 6.4.1 Corticosteroids
    • 6.4.2 Calcineurin Inhibitors
    • 6.4.3 Other Drug Options
  • 6.5 Market Segmentation By Disease Type
    • 6.5.1 Nonsegmental Vitiligo
    • 6.5.2 Segmental Vitiligo
  • 6.6 Market Segmentation By Treatment
    • 6.6.1 Medication
    • 6.6.2 Therapies
    • 6.6.3 Other Treatment Options
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Homecare
    • 6.7.3 Specialty Clinics
    • 6.7.4 Other End-Users

7 Major Market Trends

  • 7.1 Introduction Of Self-Designed Kits For Preventive Vitiligo Treatment
  • 7.2 Approval Of New Treatments Or Creams For Vitiligo Treatment
  • 7.3 Strategic Collaborations And Partnerships To Advance Vitiligo Treatment Research
  • 7.4 Investigating Clinical Trials For Next-Generation Vitiligo Therapies

8 Vitiligo Treatment Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Vitiligo Treatment Market
  • 8.2 Impact Of The War In Ukraine On The Vitiligo Treatment Market
  • 8.3 Impact Of High Inflation On The Vitiligo Treatment Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Vitiligo Treatment Market Segmentation

  • 10.1 Global Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Vitiligo Treatment Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.5 Global Medication Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Vitiligo Treatment Market, Regional and Country Analysis

  • 11.1 Global Vitiligo Treatment Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Vitiligo Treatment Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Vitiligo Treatment Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.1 China Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.2 Australia Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 South Korea Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Vitiligo Treatment Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.1 Germany Market
  • 13.11 Germany Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.2 Italy Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Major Companies
  • 14.2 Eastern Europe Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Vitiligo Treatment Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Vitiligo Treatment Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.1 USA Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Major Companies
  • 16.2 South America Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Vitiligo Treatment Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Major Companies
  • 18.2 Africa Vitiligo Treatment Market, Segmentation By Drugs Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Vitiligo Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Vitiligo Treatment Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Incyte Corporation
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Dr. Reddy's Laboratories Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Glenmark Pharmaceuticals Ltd
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Financial Overview
  • 19.5 Strides Pharma Science Limited
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Financial Overview
  • 19.6 Issar Pharmaceuticals Pvt Ltd
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Incyte Acquired Villaris Therapeutics
  • 22.2 Bristol Myers Squibb Acquired Celgene Corporation
  • 22.3 Crown Laboratories Acquired Crown Aesthetics

23 Opportunities And Strategies

  • 23.1 Global Vitiligo Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Vitiligo Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Vitiligo Treatment Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Vitiligo Treatment Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer